Jyong Biotech Ltd.
MENS
$55.24
$1.182.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -846.50K | -846.50K | -663.00K | -663.00K | -1.33M |
| Total Depreciation and Amortization | 29.00K | 29.00K | 31.00K | 31.00K | 31.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 232.00K | 232.00K | 148.50K | 148.50K | 174.00K |
| Change in Net Operating Assets | 160.00K | 160.00K | -903.00K | -903.00K | 469.50K |
| Cash from Operations | -425.50K | -425.50K | -1.39M | -1.39M | -654.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 4.58M | 4.58M | 1.26M | 1.26M | 4.68M |
| Total Debt Repaid | -4.10M | -4.10M | -630.00K | -630.00K | -3.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -51.50K | -51.50K | -55.00K | -55.00K | -123.00K |
| Cash from Financing | 424.00K | 424.00K | 571.00K | 571.00K | 657.50K |
| Foreign Exchange rate Adjustments | 2.50K | 2.50K | -6.00K | -6.00K | 9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.00K | 1.00K | -821.50K | -821.50K | 12.00K |